Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common stock, no par value (the "Shares")
-
Shares outstanding
-
34,145,841
-
Total 13F shares
-
9,638,104
-
Share change
-
-99,891
-
Total reported value
-
$46,743,906
-
Price per share
-
$4.85
-
Number of holders
-
44
-
Value change
-
-$525,691
-
Number of buys
-
18
-
Number of sells
-
12
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) as of Q1 2019
As of 31 Mar 2019,
FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,638,104 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Avoro Capital Advisors LLC, 683 Capital Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, Opaleye Management Inc., BlackRock Inc., GRANAHAN INVESTMENT MANAGEMENT INC/MA, PUTNAM INVESTMENTS LLC, UNITED SERVICES AUTOMOBILE ASSOCIATION, and STATE STREET CORP.
This page lists
44
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.